With our incredible universities, educated workforce and geographic location, I firmly believe Connecticut can be the next ...

Home-grown start-up Mirxes is going places, but co-founder is firmly rooted in Singapore. Read more at straitstimes.com. Read ...

On the flip side, ARK’s ARKG ETF parted with a significant stake in Adaptive Biotechnologies Corp (NASDAQ: ADPT ), selling 278,792 shares worth roughly $2.65 million. This sale continues a trend from ...

Curogen, one of South Korea's leading biotechnology companies focused on nanotechnology-based treatments for autoimmune diseases, today announced a series of strategic appointments that strengthen its ...

Thermo Fisher's 2025 headwinds from tariffs and US research funding cuts are real but temporary. Read why TMO stock is a ...

The entrepreneur says biotech should be less contentious than AI, as a breakthrough in Beijing is just as usable in Boston.

Such dramatic price swings aren't unusual in the biotechnology industry; in this case, disappointing data from an important ...

NanoViricides (NNVC) is presenting at the prestigious BIO International Convention on June 16th, showcasing their revolutionary broad-spectrum antiviral platform that could transform how we treat ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Stellenbosch University’s (SU’s) new incubator dedicated to biotech startups, LaunchLab CERIBio, was full even before its’ ...

The oncology giant will pay $1.5 billion to co-develop a BioNTech drug that targets the proteins PD-L1 and VEGF, following ...

This article is authored by Saransh Chaudhary, president, Global Critical Care, Venus Remedies Ltd and CEO, Venus Medicine ...